Hong Kong debut for PRC vaccine distributor

    | BY

    clpstaff &clp articles

    China NT Pharma Group Company (NT Pharma) has raised US$208 million in its initial public offering (IPO) on the Hong Kong Stock Exchange. The offering…

    China NT Pharma Group Company (NT Pharma) has raised US$208 million in its initial public offering (IPO) on the Hong Kong Stock Exchange. The offering price was HK$4.54 per share.

    The issuer is a large fully-integrated supply chain and sales provider of vaccines and pharmaceutical products in China. It plans to utilise the proceeds for expansion of the company's distribution network, infrastructure upgrade and growth of its promotion teams. Private equity firm Texas Pacific Group (TPG) will remain NT Pharma's second largest shareholder.The lead underwriters of the
    transaction were UBS and Goldman Sachs.

    This premium content is reserved for
    China Law & Practice Subscribers.

    • A database of over 3,000 essential documents including key PRC legislation translated into English
    • A choice of newsletters to alert you to changes affecting your business including sector specific updates
    • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
    For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]